Cough hypersensitivity syndrome (CHS) is a relatively new clinical concept that reframes chronic cough not as a symptom of some hidden disease but as a disorder of the cough reflex itself. The idea, first formally proposed around 2010, is that the nerves responsible for triggering cough become oversensitized, firing too easily and too often in response to stimuli that would not normally provoke coughing. This matters because millions of people with persistent cough go through round after round of testing for asthma, reflux, and sinus disease without ever getting a satisfying explanation or lasting relief. CHS gives clinicians a unifying framework and, increasingly, a path toward treatments that target the underlying nerve dysfunction rather than chasing individual triggers.
What the Diagnosis Actually Means
For decades, the standard approach to chronic cough (lasting more than eight weeks) has been to work through a checklist of likely causes: upper-airway cough syndrome from sinus problems, asthma, gastroesophageal reflux disease, and eosinophilic bronchitis. Guidelines from major respiratory societies still recommend this approach, and it works for many people. But a significant minority either have no identifiable cause or continue coughing despite successful treatment of the supposed trigger. These patients were traditionally labeled as having “unexplained” or “refractory” chronic cough. CHS offers a different way of thinking about them.
The core proposal is that most chronic cough patients share a single underlying problem: their cough reflex has become hypersensitive. Rather than treating chronic cough as a collection of separate diseases that happen to produce coughing, CHS treats it as one condition with various triggers that lower the threshold at which the cough reflex fires.1PubMed. The cough hypersensitivity syndrome: a novel paradigm for understanding cough Researchers who championed this idea argued it would shift attention toward understanding the nerve pathways driving cough and developing better antitussive drugs.2PubMed. Chronic ‘cough hypersensitivity syndrome’: a more precise label for chronic cough A validated questionnaire was developed to identify the syndrome’s key features, supporting the idea that chronic cough represents a single coherent entity rather than a grab bag of unrelated conditions.3PubMed. Cough hypersensitivity syndrome: a distinct clinical entity
Hallmark Symptoms
If you have CHS, your cough does not just happen more often; it happens in ways that feel qualitatively different from a normal cough. Clinicians look for two characteristic patterns borrowed from the language of pain research. The first is hypertussia, which means coughing excessively in response to something that would make anyone cough, like inhaling smoke or strong fumes, but the reaction is disproportionately intense and prolonged. The second is allotussia, which means coughing in response to things that should not trigger cough at all, such as talking, laughing, singing, eating, temperature changes, or even certain perfumes.
Many people with CHS also describe a persistent tickle, itch, or irritation in the throat that precedes the cough. This sensation, sometimes called laryngeal paraesthesia, often sits right at the base of the throat or behind the voice box and can feel impossible to clear. It is not a sign of infection or structural damage; it is a manifestation of the sensitized nerves misfiring. The combination of these features, exaggerated coughing to ordinary irritants plus coughing to normally harmless triggers plus a constant throat sensation, forms the clinical fingerprint of CHS.4The Lancet Respiratory Medicine. Cough and asthma in adults and children
What Is Happening in the Nerves
Two layers of dysfunction drive CHS, one in the airways and one in the brain. On the peripheral side, the vagus nerve branches that innervate the throat and airways become hyperexcitable. One clinical sign of this is the Arnold nerve reflex: touching or probing the ear canal triggers a cough because a branch of the vagus nerve supplies sensation there. In people with chronic cough, this reflex appears far more frequently than in healthy individuals, and it resolves once the cough is effectively treated, suggesting it reflects the same vagal hypersensitivity driving the cough itself.5Chest. Arnold Nerve Reflex: Vagal Hypersensitivity in Chronic Cough With Various Causes
On the central side, brain-imaging studies have found that people with CHS show heightened neural activity in midbrain regions involved in processing cough signals, particularly the periaqueductal gray and a nearby area called the nucleus cuneiformis. At the same time, these patients show reduced activity in the prefrontal and cingulate cortical networks that normally allow you to suppress an urge to cough. In other words, the “volume” on cough signals is turned up and the brain’s “mute button” is turned down.6Thorax. Neural correlates of cough hypersensitivity in humans: evidence for central sensitisation and dysfunctional inhibitory control Structural brain changes, including reduced grey matter volume, have also been reported in CHS patients, hinting that long-standing cough hypersensitivity may physically remodel the brain over time.7European Respiratory Society. Peripheral and central mechanisms of cough hypersensitivity
Common Triggers and Overlapping Conditions
CHS does not exist in a vacuum. It frequently overlaps with conditions that traditional cough guidelines have long identified as causes of chronic cough. The difference under the CHS framework is that these conditions are seen as triggers that sensitize the cough reflex rather than as independent causes that fully explain the cough.
Reflux is among the most common. Laryngopharyngeal reflux, where stomach contents reach the throat, is associated with chronic cough, hoarseness, and a persistent throat-clearing habit.8PubMed Central. Laryngopharyngeal Reflux and Functional Laryngeal Disorder: Perspective and Common Practice of the General Gastroenterologist One study found that reflux events alone increased coughing roughly 1.5-fold, and when combined with talking, that figure rose to about 1.7-fold.9PubMed Central. Airway Hypersensitivity, Reflux, and Phonation Contribute to Chronic Cough This helps explain why many CHS patients notice their cough worsens during or after meals and during conversations.
Asthma and eosinophilic bronchitis are other frequent co-travelers. Eosinophilic inflammation in the airways can directly heighten the sensitivity of cough nerves. In patients with eosinophilic bronchitis, treatment with inhaled corticosteroids not only reduced eosinophil counts but also improved capsaicin cough sensitivity toward normal levels, confirming the link between airway inflammation and nerve sensitization.10CHEST. Chronic Cough Due to Nonasthmatic Eosinophilic Bronchitis: ACCP Evidence-Based Clinical Practice Guidelines Similarly, in asthma, cough hypersensitivity with laryngeal paraesthesia and allotussia may underlie the cough through increased excitability of upper-airway vagal sensory nerves.4The Lancet Respiratory Medicine. Cough and asthma in adults and children
How Doctors Diagnose CHS
There is no single blood test or scan that confirms CHS. The diagnosis is primarily clinical, resting on the pattern of symptoms described above and, critically, on the exclusion or adequate treatment of known causes. The CHEST guideline still recommends systematically working through the major causes of chronic cough, because many patients do improve with targeted treatment for reflux, asthma, or sinus disease.11PubMed Central. Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report CHS enters the picture when those treatments fail or when the clinical picture strongly suggests nerve hypersensitivity from the outset.
Several tools help clinicians measure the severity and character of cough. Questionnaires such as the Leicester Cough Questionnaire and the newer McMaster Cough Severity Questionnaire allow standardized assessment. The McMaster instrument, for example, showed high internal consistency and strong correlation with visual analogue scale ratings of cough severity in validation studies.12PubMed Central. The McMaster Cough Severity Questionnaire (MCSQ): a cough severity instrument for patients with refractory chronic cough A dedicated cough hypersensitivity questionnaire, the Newcastle Laryngeal Hypersensitivity Questionnaire, specifically asks about the paraesthesia and trigger patterns characteristic of CHS.
Some specialist centres use capsaicin cough provocation tests, where you inhale escalating concentrations of capsaicin (the compound that makes chili peppers burn) and clinicians record when coughing begins. Patients with chronic cough show significantly lower thresholds for coughing in these tests compared to healthy controls, and these thresholds can reliably discriminate between the two groups.13PubMed. Capsaicin cough threshold test in diagnostics Updated reference ranges have been developed so that results can be interpreted against a healthy population baseline.14PubMed Central. Utility of Cough Provocation Tests in Chronic Cough and Respiratory Diseases: A Comprehensive Review and Introduction of New Reference Ranges for the Capsaicin Test These tests are not yet routine in everyday practice, but they are increasingly used in clinical trials and referral centres to objectively confirm cough hypersensitivity.
Neuromodulator Medications
Because CHS is essentially a nerve-sensitization problem, drugs that calm nerve signaling have become a mainstay of treatment. Gabapentin, originally developed for epilepsy and later widely used for neuropathic pain, is the best-studied neuromodulator for chronic cough. A systematic review found that gabapentin improved cough-specific quality of life and reduced cough severity compared with placebo or standard medications, with an overall improvement rate of about 68% in prospective case series.15Tuberculosis and Respiratory Diseases. Efficacy and Safety of Gabapentin in the Treatment of Chronic Cough: A Systematic Review The benefit appears greatest in patients with prominent laryngeal paraesthesia, hypertussia, and allotussia, the hallmarks of central sensitization.16PubMed. Gabapentin in chronic cough
Pregabalin, a related medication, has also shown promise. However, a meta-analysis pooling neuromodulator trials found that while treated patients reported better cough-related quality of life (a clinically meaningful improvement), the reductions in cough frequency and severity visual analogue scale scores fell short of clear clinical significance.17PubMed. A systematic review and meta-analysis of neuromodulators to treat chronic airway hypersensitivity The common side effects of these drugs, particularly drowsiness and dizziness, limit their long-term tolerability for some people. And cough frequently returns when the medication is stopped, which highlights that neuromodulators manage the sensitization rather than cure it.
Speech Therapy and Cough Suppression Techniques
A non-drug approach that has gained strong support in the CHS world is cough suppression therapy, typically delivered by a speech-language pathologist. The program usually includes education about the cough reflex, laryngeal hygiene strategies (hydration, reducing throat clearing), breathing exercises, and specific techniques for voluntarily suppressing the urge to cough. A randomized controlled trial found significant reductions in cough symptoms with this approach, and other studies have shown improvements in quality of life, reduced cough reflex sensitivity, and lower cough frequency.18PubMed. Cough suppression therapy: does it work?
This may sound like telling someone to just stop coughing, but the actual techniques are more nuanced. You learn to recognize the pre-cough sensation early and respond with a controlled breathing maneuver or a swallow instead of giving in to the urge. Over time, this retrains the reflex arc. Many specialist centres now combine speech therapy with neuromodulators, treating the condition from both the pharmacological and behavioral sides simultaneously.
Emerging Drug Targets
The biggest news in cough treatment in recent years involves a class of drugs that block the P2X3 receptor, a protein on sensory nerve endings that responds to ATP (a signaling molecule released by damaged or irritated airway cells). A meta-analysis of eleven randomized controlled trials found that P2X3 receptor antagonists significantly reduced cough frequency, severity, and impact on quality of life in people with refractory chronic cough.19PubMed. Safety and efficacy of P2X3 receptor antagonist for the treatment of refractory or unexplained chronic cough: A systematic review and meta-analysis of 11 randomized controlled trials The main catch is a side effect involving altered taste, ranging from reduced taste to complete loss, because P2X3 receptors also play a role in taste sensation. Newer, more selective versions of these drugs are in development aimed at preserving cough efficacy while reducing taste disturbance.
Beyond P2X3 antagonists, researchers are exploring drugs that target transient receptor potential (TRP) channels and neurokinin receptors, both of which sit on the sensory nerves involved in cough. The goal with all of these approaches is to dial down the nerve hypersensitivity that defines CHS without wiping out the protective cough reflex entirely.20PubMed. Drugs Targeting Cough Receptors: New Therapeutic Options in Refractory or Unexplained Chronic Cough
Why This Seems to Be an Adult Problem
One intriguing observation is that CHS appears to be far less common, or perhaps does not exist in the same form, in children. The Arnold nerve reflex, a marker of vagal hypersensitivity, was found to be more than twelve times more prevalent in adults with chronic cough than in healthy adult volunteers, but no such increase was seen among children with chronic cough. The researchers concluded that CHS may be an acquired condition, potentially triggered by viral respiratory infection or other environmental insults that accumulate over a lifetime.21Chest. Prevalence of Arnold Nerve Reflex in Adults and Children With Chronic Cough Children’s chronic cough tends to have different causes and a different physiology, and experts have argued that applying the CHS label to pediatric patients is premature and potentially misleading.22PubMed Central. Cough Hypersensitivity Syndrome: Why Its Use Is Inappropriate in Children
The Role of Infections in Triggering Cough Hypersensitivity
Many people with CHS trace the onset of their cough to a respiratory infection. The cough from the cold goes away for everyone else, but theirs never stops. This observation fits with the idea that infection-driven inflammation can damage or reprogram the sensory nerves in the airways, leaving them in a persistently hyperexcitable state, a process analogous to how nerve injury can lead to chronic neuropathic pain.23PubMed Central. Approach to chronic cough: the neuropathic basis for cough hypersensitivity syndrome
COVID-19 has brought renewed attention to this mechanism. Researchers hypothesized that SARS-CoV-2 infection could trigger cough hypersensitivity through neurotropism (the virus invading nerve tissue), neuroinflammation, and disruption of neuroimmune signaling along the vagal sensory nerves.24PubMed Central. Confronting COVID-19-associated cough and the post-COVID syndrome: role of viral neurotropism, neuroinflammation, and neuroimmune responses Post-COVID cough has introduced large numbers of new patients to cough specialists and has helped raise awareness of CHS as a concept, though the long-term trajectory of post-COVID cough hypersensitivity remains an area of active study.
Living With Chronic Cough
The quality-of-life burden of CHS is routinely underestimated by people who do not have it. Chronic cough can cause urinary incontinence, rib fractures, headaches, disrupted sleep, and social withdrawal. The social dimension became especially acute during the COVID-19 pandemic, when coughing in public attracted fear and hostility, deepening the isolation that chronic cough patients already experience.25PubMed Central. Impact and disease burden of chronic cough The emotional toll, economic impact through medical costs and lost productivity, and social withdrawal interact in a cycle that repeated treatment failures only worsen.
This is one reason the CHS framework matters beyond academic reclassification. When your cough is treated as a mystery to be solved through ever more specialist referrals, each failed treatment compounds the frustration. When it is recognized as a nerve-sensitization disorder with specific characteristics and targeted treatments, you at least have a name for what is happening and a rational plan for managing it.
The Placebo Problem in Cough Research
Developing better drugs for CHS faces an unusual scientific obstacle: patients in clinical trials who receive a placebo pill often improve substantially. This large placebo response makes it harder to prove that a new drug works better than nothing, and it has complicated the regulatory pathway for several promising medications.26PubMed Central. Decoding the impact of the placebo response in clinical trials for chronic cough The mechanisms behind this are not fully understood but likely involve both psychological factors (expectation of benefit, the reassurance of being monitored) and genuine neurobiological effects, since placebo responses can alter activity in the very brain circuits involved in cough suppression.27The Lancet Respiratory Medicine. Mechanisms and mitigation of placebo responses in refractory chronic cough trials Researchers are now designing trials with run-in periods and objective cough monitoring to minimize this confounding effect, but it remains one of the field’s most significant practical challenges.
Evolutionary Origins of the Cough Reflex
Cough exists because it protects the lungs from aspiration and inhaled debris, but the reflex itself is not a single monolithic thing. Research suggests there are at least two distinct types. One is a fast mechanical reflex carried by myelinated nerve fibers that responds to physical intrusion into the airway. This type likely evolved as the human larynx moved closer to the esophageal opening to accommodate the development of speech, an anatomical trade-off that increased the risk of food entering the airway. The second type is a slower, chemical reflex carried by unmyelinated C fibers, the same fibers involved in pain. This version may have evolved as humans began living in dense communities and faced greater exposure to respiratory infections and airborne irritants.28PubMed Central. Perspective on the human cough reflex CHS appears to involve dysregulation primarily of this second, chemically sensitive pathway, essentially the same pathway that mediates chronic pain after tissue injury.29PubMed Central. Cough Hypersensitivity Syndrome: A Few More Steps Forward The parallel with chronic pain is not just a metaphor; it has directly informed the use of pain medications like gabapentin for cough and continues to guide the search for new treatments.